Harris’ California health care battles signal fights ahead for hospitals if she wins

FHS
August 5, 2024
10:30 am

When Kamala Harris was California’s top prosecutor, she was concerned that mergers among hospitals, physician groups, and health insurers could thwart competition and lead to higher prices for patients.

Triple Combination Therapy by Novartis for Malaria: Likelihood of Approval – Pharmaceutical Technology

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

January 5, 2024

Broad Institute announces layoffs, largely in IT, software engineering

The Broad Institute of MIT and Harvard, one of the most prominent biotech research centers in the world, has laid off 87 employees, a spokesperson confirmed.

October 14, 2024

Otsuka snaps up Jnana with its phenylketonuria drug for $800m

Otsuka will gain Jnana’s lead candidate JNT-517 for treating phenylketonuria (PKU), along with its drug discovery RAPID chemoproteomics platform. Image Credit: Ratana21 / Shutterstock. Otsuka

August 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.